Screening found 32,342 diabetes cases in nine months, the Health Ministry says

Illustrative photo: a glucose meter with a test strip
Illustrative photo. Source: Anelya Topoleva / Wikimedia Commons, CC BY-SA 4.0

Astana, 14 November. Free screening detected 32,342 cases of diabetes in Kazakhstan in the first nine months of 2026, and in total more than 575,000 people in the country are registered with the diagnosis.

  • Diabetes in Kazakhstan

    • more than 575,000
      patients as of 1 October 2026
    • 30,987
      of them with type 1 diabetes
    • more than 1.6 million
      screened in nine months
    • 32,342
      cases detected
    • more than 60 billion tenge
      for medicines in 2026

    According to the Ministry of Health of Kazakhstan

The Ministry of Health released the figures for World Diabetes Day, which is marked on 14 November.

More than 1.6 million people have been examined since the start of the year, and almost 95% of the patients identified have been placed under regular observation. Screening was expanded this year: residents aged 40 to 76 undergo it once every two years, and the programme includes tests for glycated haemoglobin, triglycerides and low-density lipoproteins. These tests, according to the ministry, help to find the disease at an early stage and start treatment in time.

Of the 575,000 registered patients, 30,987 live with type 1 diabetes; the figures are as of 1 October. A year ago, the ministry reported for the same day, more than 558,000 people were on the dispensary register, 95% of them with type 2 diabetes. Over the year the number of patients has thus grown by about 17,000.

Spending has grown too. In 2026 the state allocated more than 60 billion tenge to supplying medicines to patients with diabetes — about a quarter of all funding for the provision of medicines. A year earlier the ministry named about 46 billion tenge, or 22%. “Diabetes is among the diseases that require the greatest spending on drug therapy,” the ministry noted.

With this money patients receive insulins, glucose-lowering drugs in tablets and injections, glucose meters, test strips, insulin pumps and consumables for them. The supply of insulin pumps and consumables to patients under 21 and to pregnant women has been expanded. Deliveries of drugs to medical organisations, the ministry says, have been made since January according to approved schedules.

A Republican Competence Centre for Endocrinology and Diabetes has been set up at the Research Institute of Cardiology and Internal Diseases. Its regional branches operate in six regions: Almaty, Karaganda, Kyzylorda, North Kazakhstan, Turkistan and Aktobe. Such centres are planned to open in all regions by the end of 2027. The network of Diabetes Schools at outpatient clinics is being expanded; there patients are taught to monitor their blood sugar themselves and to prevent complications.

What it means: The number of people with diabetes in Kazakhstan is growing: over the year it rose by about 17,000, and medicines for them already take about a quarter of all funding for the provision of medicines. The emphasis is on early detection, which is why screening has been expanded both in age range and in the set of tests.

What to do: Residents aged 40 to 76 can be screened free of charge at their own clinic once every two years. Since 2026, according to the Ministry of Health, screening has been part of the guaranteed volume of free medical care. Status in the compulsory social health insurance (CSHI) system does not matter for this. To prevent type 2 diabetes the ministry advises watching body weight, cutting down on sugar, flour products and sweet drinks, and being active for at least 30 minutes a day.

Background: Diabetes, as defined by the World Health Organization (WHO), is a chronic disease in which the pancreas does not produce enough insulin or the body cannot use it effectively. Insulin is a hormone that regulates blood glucose. The number of people living with diabetes worldwide, according to the WHO, rose from 200 million in 1990 to 830 million in 2022. A year ago the ministry said that from January 2026 the financing of diabetes treatment would move to the CSHI system.

We have also reported on a proposal to start screening for cardiovascular diseases from the age of 18.